New Zealand is the world’s third-largest honey exporter by value behind China and Argentina and honey accounts for up to 80 % of New Zealand’s exports. However, it is only the 16th biggest global supplier by volume. Manuka honey from New Zealand is sold for premium prices and merchandised for its health benefits. Because of its exceptional antibacterial effect, there is a strong market demand and the price for a kilogram of manuka honey has tripled in recent years (Ministry for Primary Industries 2015). When consumers are willing to pay prices up to 200 €/kg manuka honey, the risk of misleading advertisement and intended fraud increases. This thesis aims to further characterize manuka honey and contribute to the development of a manuka honey definition. The first part deals with the antibacterial activity of manuka honey. The effect of manuka honey is mainly due to methylglyoxal, whereas the effect of non-manuka honeys is primarily caused by hydrogen peroxide. The objective is to develop a method to quantify the effect solely due to one of the respective chemical compounds and compare their effectiveness. Finally, an evaluation of the contribution of methylglyoxal and hydrogen peroxide to the inhibitory effect of honey should be given. The second part deals with chemical reactions of carbonyl compounds in honey. Because of the reactive nature of carbonyl compounds, the formation of specific glycation compounds in honey is assumed. Since the carbonyl profile of manuka honey differs remarkably from non-manuka honeys, the reaction products are expected to vary widely. Specific compounds, solely present in manuka honey, could serve as quality control parameters to ensure manuka honey authenticity. The final part deals with the metabolism of food-derived carbonyl compounds. Carbonyl compounds, like methylglyoxal or 3-deoxyglucosone are discussed to be potentially toxic to human tissues. Until now, only little is known about the impact of the diet on the physiological carbonyl-load and the metabolism of carbonyl compounds. With the help of nutrition studies and the analysis of body fluids, the question of metabolic transit of carbonyl compounds shall be addressed. The antibacterial studies showed that bacterial species are affected differently by bioactive compounds present in honey. Methylglyoxal (MGO), which is solely present in manuka honeys and hydrogen peroxide, which is formed in most conventional honeys by glucose oxidase, are strong inhibitors of the growth of S. aureus and E. coli. The strain of P. aeruginosa used for this work was not inhibited by MGO, whereas B. subtilis was not inhibited by hydrogen peroxide. To compare and quantify the effect of MGO and hydrogen peroxide, a mathematic model was created. By comparing the slopes of the linearized dose-response curves, it was found that S. aureus, E. coli and P. aeruginosa were more sensitive to hydrogen peroxide than to MGO. However, the natural amounts of MGO in honey are higher than the formation of hydrogen peroxide. Although most bacteria are more sensitive to hydrogen peroxide, MGO is the predominantly antibacterial compound in honey, because of its higher concentrations compared to hydrogen peroxide formation. The inclusion of manuka honey in α-cyclodextrin had only minor consequences on bioavailability and antibacterial activity. The commercial product “Cyclopower” (α-cyclodextrin with manuka honey) does not enhance the antibacterial activity of manuka honey on S. aureus, E. coli and P. aeruginosa. With the help of the newly developed quantitative model, it was shown that the growth of B. subtilis is synergistically inhibited with cyclopower compared to manuka honey and α-cyclodextrin alone. The study of bacterial enzymes as possible targets for bacterial inhibition with manuka honey revealed that MGO and DHA inhibited jack bean urease, which was used as a model for Helicobacter pylori urease. The concentration of MGO and DHA in manuka honey positively correlated with its urease inhibition. Conventional honeys, which lack MGO and DHA, showed significantly less urease inhibition. Based on the unique presence of MGO, manuka honey has extraordinary effects on bacteria, which might lead to further application to fight the emerging crisis of antibacterial resistance to antibiotics. Until now, there is no consistent definition for the term “genuine manuka honey”. In the present work, an approach based on unique chemical reactions in manuka honey was followed. It was shown that the exceptional high amounts of MGO induced the formation of 2-acetyl-1-pyrroline (2-AP). In manuka honey containing ≥ 250 mg/kg MGO, the 2-AP concentration was significantly increased compared to conventional honey. Moreover, honey proteins form MGO-derived reactions products, which were studied by measuring the molecular size of honey proteins. Manuka honey proteins significantly shifted to high molecular weights (HMW) with a size above 510 kDa. The amount of HMW protein in non-manuka honey was significantly lower. The cleavage of disulphide bonds led to a decrease of HMW fraction of conventional honeys but not of manuka honeys. It is hypothesized that MGO cross-linking of proteins is mainly responsible for the formation of HMW adducts in manuka honey. The formation of HMW adducts was also shown with fluorescence analysis, whereby manuka honey proteins had higher fluorescence intensities at λex=350 nm and λem=450 nm compared to non-manuka honeys. The artificial addition of MGO and its precursor dihydroxyacetone (DHA) to a non-manuka honey did not lead to an increased fluorescence up to the level of commercial manuka honeys. The MGO-derived modifications of proteins were further studied by quantifying the protein-bound Maillard reaction products N-ε-carboxyethyllysine (CEL) and methylglyoxal-derived hydroimidazolone 1 (MG-H1) after enzymatic hydrolysis of honey proteins and LC-MS/MS analysis. Their amount was significantly higher in manuka compared to conventional honeys and correlated with the MGO content of the honey. Most of the MGO-derived reactions could be simulated by spiking a conventional honey or a low MGO manuka honey with artificial MGO and subsequent storage at elevated temperatures. Higher storage temperatures were associated with a quick increase of 5-hydroxymethylfurfuraldehyd (HMF). The HMF level in honey is used as a quality parameter and should not exceed 40 mg/kg (Codex Alimentarius Commission, 2001). High concentrations of HMF may point to a fraudulent addition of MGO and the production of artificial high-price manuka honey products. Taken together, the Maillard reaction in honey could be used to control the natural origin of MGO and DHA. The consumption of honey and especially manuka honey exposes humans to high levels of dietary dicarbonyl compounds like MGO and 3-deoxyglucosone (3-DG). Both compounds were discussed as potential risk factors for the development of age-related diseases. The simulated digestion of manuka honey in the presence of gastric and ileal fluids showed that only 9 % of the initial concentration can be recovered after 8 h. The honey matrix had no stabilising effect on MGO compared to a synthetic MGO solution. In contrast to MGO, the manuka honey compound DHA was stable during all simulated digestion steps. The complexation of MGO with α-cyclodextrin did not enhance the stability of MGO. The metabolic transit of dietary MGO and 3-DG was further studied with an intervention study with healthy volunteers, who collected their daily urine. It was shown that urinary concentrations of 3-DG and its less reactive metabolites 3-deoxyfructose (3-DF) and 2-keto-3-deoxygluconic acid (3-DGA), but not MGO, were influenced by the diet. During the intervention studies, up to 40 % of dietary 3-DG was recovered as the sum of 3-DG, 3-DF and 3-DGA. The metabolite 3-DGA only played a minor role in the metabolism of dietary 3-DG in comparison to 3-DF. The concentrations 3-DF and 3-DGA in plasma only increased after the consumption of dietary 3-DG and not after the uptake of carbohydrate rich meals in general. This led to the conclusion that dietary 3-DG is effectively metabolized to 3-DF extracellularly on the apical site of the intestinal epithelium and is resorbed slowly into the circulation. In contrast, 3-DG, which is formed (intracellularly) postprandial from glucose, bypasses this metabolic system and cannot be metabolized as rapidly to 3-DF. Preliminary results obtained with saliva instead of urine as a bio fluid to study the dietary influence of dicarbonyl compounds, confirmed the hypothesis. Based on the present results, dietary dicarbonyl compounds are effectively metabolized during digestion.

Commercially available titanium (Ti) alloys, such as Ti–6Al–4V and c.p. Ti, even though established in clinical use as load-bearing bone implant materials in orthopedics and dentistry, possess significant drawbacks that may lead to implant failure: i) presence of alloying elements with harmful health effects, ii) high Young’s modulus (E > 100 GPa) compared to human cortical bone (Ebone = 10 – 30 GPa), and iii) lack of antibacterial activity against multidrug-resistant bacteria, which may lead to implant-associated infections. To overcome the first two drawbacks, a new generation of biocompatible metastable β-type Ti alloys has been developed, in particular β-type Ti–Nb alloys, which are versatile candidates due to their low Young’s modulus, high strength-to-weight ratio and improved corrosion resistance. The present work aims to tackle all three aforementioned issues by developing novel β-type Ti–45Nb-based alloys with potential intrinsic antibacterial activity by adding antibacterial gallium (Ga) and copper (Cu) in minor amounts (up to 8 wt.%) via metallurgical route. Nine alloys with the following chemical compositions: (100-x)(Ti–45Nb)–xGa, (100-x)(Ti–45Nb)–xCu (where x = 2, 4, 6, 8 wt.%), and 96(Ti–45Nb)–2Ga–2Cu, based on alloy design approaches, were produced by controlled casting and homogenization treatment. The effect of antibacterial alloying additions on phase constitution, mechanical characteristics, corrosion, and tribocorrosion response in a simulated physiological environment has been investigated. All nine alloys in the homogenized state display a single-phase β (BCC) phase microstructure, whose lattice parameter is proved to be sensitive to Ga and Cu content, with an almost linear contraction. The mechanical characteristics are strongly influenced by Ga and Cu addition, with a general strengthening effect mainly attributed to substitutional solid solution strengthening, and to grain boundary strengthening in case of Ga. Deformation behavior indicates high mechanical stability of the β phase, suggesting dislocation slip as dominant deformation mechanism. The results demonstrate that strategic alloy design is an effective method to significantly increase strength without adversely affecting the Young’s modulus, which remains in the range of good biomechanical compatibility (E = 64 – 104 GPa). Evaluation of the corrosion response and metal ion release in simulated physiological environment demonstrates the high corrosion resistance of the nine alloys, whereas tribocorrosion wear resistance increases upon Ga addition. Further thermal (aging) treatments, carried out on a specific Cu-containing alloy, proved the feasibility of tailoring enhanced mechanical, chemical and potentially antibacterial properties by thermally-induced precipitation of Ti₂Cu intermetallic compound. These novel developed alloys are considered to be promising candidates for biomedical bone implant applications.

Reaction of BiPh3 or Bi(OtBu)3 with benzohydroxamic acid (H2-BHA) results in formation of novel mono- and di-anionic hydroxamato complexes; [Bi2(BHA)3]∞1, [Bi(H-BHA)3] 2, [Bi(BHA)(H-BHA)] 3, all of which display nM activity against Helicobacter pylori. Subsequent dissolution of [Bi2(BHA)3]∞ in DMSO/toluene results in hydrolysis to the first structurally authenticated {Bi34} oxido-cluster [Bi34O22(BHA)22(H-BHA)14(DMSO)6] 4. / Dieser Beitrag ist aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.

New Zealand is the world’s third-largest honey exporter by value behind China and Argentina and honey accounts for up to 80 % of New Zealand’s exports. However, it is only the 16th biggest global supplier by volume. Manuka honey from New Zealand is sold for premium prices and merchandised for its health benefits. Because of its exceptional antibacterial effect, there is a strong market demand and the price for a kilogram of manuka honey has tripled in recent years (Ministry for Primary Industries 2015). When consumers are willing to pay prices up to 200 €/kg manuka honey, the risk of misleading advertisement and intended fraud increases. This thesis aims to further characterize manuka honey and contribute to the development of a manuka honey definition. The first part deals with the antibacterial activity of manuka honey. The effect of manuka honey is mainly due to methylglyoxal, whereas the effect of non-manuka honeys is primarily caused by hydrogen peroxide. The objective is to develop a method to quantify the effect solely due to one of the respective chemical compounds and compare their effectiveness. Finally, an evaluation of the contribution of methylglyoxal and hydrogen peroxide to the inhibitory effect of honey should be given. The second part deals with chemical reactions of carbonyl compounds in honey. Because of the reactive nature of carbonyl compounds, the formation of specific glycation compounds in honey is assumed. Since the carbonyl profile of manuka honey differs remarkably from non-manuka honeys, the reaction products are expected to vary widely. Specific compounds, solely present in manuka honey, could serve as quality control parameters to ensure manuka honey authenticity. The final part deals with the metabolism of food-derived carbonyl compounds. Carbonyl compounds, like methylglyoxal or 3-deoxyglucosone are discussed to be potentially toxic to human tissues. Until now, only little is known about the impact of the diet on the physiological carbonyl-load and the metabolism of carbonyl compounds. With the help of nutrition studies and the analysis of body fluids, the question of metabolic transit of carbonyl compounds shall be addressed. The antibacterial studies showed that bacterial species are affected differently by bioactive compounds present in honey. Methylglyoxal (MGO), which is solely present in manuka honeys and hydrogen peroxide, which is formed in most conventional honeys by glucose oxidase, are strong inhibitors of the growth of S. aureus and E. coli. The strain of P. aeruginosa used for this work was not inhibited by MGO, whereas B. subtilis was not inhibited by hydrogen peroxide. To compare and quantify the effect of MGO and hydrogen peroxide, a mathematic model was created. By comparing the slopes of the linearized dose-response curves, it was found that S. aureus, E. coli and P. aeruginosa were more sensitive to hydrogen peroxide than to MGO. However, the natural amounts of MGO in honey are higher than the formation of hydrogen peroxide. Although most bacteria are more sensitive to hydrogen peroxide, MGO is the predominantly antibacterial compound in honey, because of its higher concentrations compared to hydrogen peroxide formation. The inclusion of manuka honey in α-cyclodextrin had only minor consequences on bioavailability and antibacterial activity. The commercial product “Cyclopower” (α-cyclodextrin with manuka honey) does not enhance the antibacterial activity of manuka honey on S. aureus, E. coli and P. aeruginosa. With the help of the newly developed quantitative model, it was shown that the growth of B. subtilis is synergistically inhibited with cyclopower compared to manuka honey and α-cyclodextrin alone. The study of bacterial enzymes as possible targets for bacterial inhibition with manuka honey revealed that MGO and DHA inhibited jack bean urease, which was used as a model for Helicobacter pylori urease. The concentration of MGO and DHA in manuka honey positively correlated with its urease inhibition. Conventional honeys, which lack MGO and DHA, showed significantly less urease inhibition. Based on the unique presence of MGO, manuka honey has extraordinary effects on bacteria, which might lead to further application to fight the emerging crisis of antibacterial resistance to antibiotics. Until now, there is no consistent definition for the term “genuine manuka honey”. In the present work, an approach based on unique chemical reactions in manuka honey was followed. It was shown that the exceptional high amounts of MGO induced the formation of 2-acetyl-1-pyrroline (2-AP). In manuka honey containing ≥ 250 mg/kg MGO, the 2-AP concentration was significantly increased compared to conventional honey. Moreover, honey proteins form MGO-derived reactions products, which were studied by measuring the molecular size of honey proteins. Manuka honey proteins significantly shifted to high molecular weights (HMW) with a size above 510 kDa. The amount of HMW protein in non-manuka honey was significantly lower. The cleavage of disulphide bonds led to a decrease of HMW fraction of conventional honeys but not of manuka honeys. It is hypothesized that MGO cross-linking of proteins is mainly responsible for the formation of HMW adducts in manuka honey. The formation of HMW adducts was also shown with fluorescence analysis, whereby manuka honey proteins had higher fluorescence intensities at λex=350 nm and λem=450 nm compared to non-manuka honeys. The artificial addition of MGO and its precursor dihydroxyacetone (DHA) to a non-manuka honey did not lead to an increased fluorescence up to the level of commercial manuka honeys. The MGO-derived modifications of proteins were further studied by quantifying the protein-bound Maillard reaction products N-ε-carboxyethyllysine (CEL) and methylglyoxal-derived hydroimidazolone 1 (MG-H1) after enzymatic hydrolysis of honey proteins and LC-MS/MS analysis. Their amount was significantly higher in manuka compared to conventional honeys and correlated with the MGO content of the honey. Most of the MGO-derived reactions could be simulated by spiking a conventional honey or a low MGO manuka honey with artificial MGO and subsequent storage at elevated temperatures. Higher storage temperatures were associated with a quick increase of 5-hydroxymethylfurfuraldehyd (HMF). The HMF level in honey is used as a quality parameter and should not exceed 40 mg/kg (Codex Alimentarius Commission, 2001). High concentrations of HMF may point to a fraudulent addition of MGO and the production of artificial high-price manuka honey products. Taken together, the Maillard reaction in honey could be used to control the natural origin of MGO and DHA. The consumption of honey and especially manuka honey exposes humans to high levels of dietary dicarbonyl compounds like MGO and 3-deoxyglucosone (3-DG). Both compounds were discussed as potential risk factors for the development of age-related diseases. The simulated digestion of manuka honey in the presence of gastric and ileal fluids showed that only 9 % of the initial concentration can be recovered after 8 h. The honey matrix had no stabilising effect on MGO compared to a synthetic MGO solution. In contrast to MGO, the manuka honey compound DHA was stable during all simulated digestion steps. The complexation of MGO with α-cyclodextrin did not enhance the stability of MGO. The metabolic transit of dietary MGO and 3-DG was further studied with an intervention study with healthy volunteers, who collected their daily urine. It was shown that urinary concentrations of 3-DG and its less reactive metabolites 3-deoxyfructose (3-DF) and 2-keto-3-deoxygluconic acid (3-DGA), but not MGO, were influenced by the diet. During the intervention studies, up to 40 % of dietary 3-DG was recovered as the sum of 3-DG, 3-DF and 3-DGA. The metabolite 3-DGA only played a minor role in the metabolism of dietary 3-DG in comparison to 3-DF. The concentrations 3-DF and 3-DGA in plasma only increased after the consumption of dietary 3-DG and not after the uptake of carbohydrate rich meals in general. This led to the conclusion that dietary 3-DG is effectively metabolized to 3-DF extracellularly on the apical site of the intestinal epithelium and is resorbed slowly into the circulation. In contrast, 3-DG, which is formed (intracellularly) postprandial from glucose, bypasses this metabolic system and cannot be metabolized as rapidly to 3-DF. Preliminary results obtained with saliva instead of urine as a bio fluid to study the dietary influence of dicarbonyl compounds, confirmed the hypothesis. Based on the present results, dietary dicarbonyl compounds are effectively metabolized during digestion.

Reaktion von Arginin mit Abbauprodukten 1,4-verknüpfter Disaccharide Im Verlauf der Reaktion von Arginin mit Abbauprodukten 1,4-glycosidisch verknüpfter Disaccharide entsteht ein Hauptderivatisierungsprodukt des Arginins, welches aus Inkubationsansätzen von Lactose mit N-(tert-Butoxycarbonyl)-L-arginin (Boc-Arg) bzw. N-a-Hippuryl-L-arginin (Hip-Arg) isoliert und als N-d-[5-(3-Hydroxypropyl)-4-oxo-imidazolon-2-yl]-L-ornithin (PIO) identifiziert werden konnte. PIO stellt ein spezifisches Reaktionsprodukt von Arginin mit Abbauprodukten 1,4-glycosidisch verknüpfter Disaccharide dar. Zum Nachweis des Precursors von PIO wurden die Bildung und der Abbau von 1,2-Dicarbonylverbindungen in Inkubationsansätzen von Lactose mit und ohne Hip-Arg nach der Hitzebehandlung mit o-Phenylendiamin untersucht. Es zeigte sich, dass ein als 1,2-Dicarbonylverbindung identifiziertes Abbauprodukt von Lactose nur in Abwesenheit von der Aminokomponente (Hip-Arg) als Hauptabbauprodukt bestimmbar war. Nach Isolierung dieser 1,2-Dicarbonylverbindung in Form ihres stabilen Chinoxalin-Derivates und der Strukturaufklärung ist es gelungen, dieses Hauptabbauprodukt der Lactose als (3'-Hydroxypropyl)-chinoxalin also das Chinoxalin der 3,4-Didesoxypentosulose (3,4-DDPs) zu identifizieren. Bestimmung von 1,2-Dicarbonylverbindungen in Lebensmitteln Glyoxal (GO), Methylglyoxal (MGO), 3-Desoxyglucosulose (3-DG) und 3-Desoxypentosulose (3-DPs) konnten nach Umsetzung mit o-Phenylendiamin erstmals in Milch- und Milchprodukten quantifiziert werden. Für Glyoxal wurden Gehalte von 0,06 bis 3,5 mg/ l und für Methylglyoxal von 0,2 bis 4,7 mg/ l bestimmt. 3-Desoxyglucosulose wurde mit Gehalten von 0,7 bis 3,5 mg/ l und 3-Desoxypentosulose von 0,1 bis 4,7 mg/ l bestimmt. Des Weiteren erfolgte die Bestimmung von Glyoxal, Methylglyoxal und 3-Desoxyglucosulose in käuflich erworbenen deutschen Honigen, in Honigen des Imkerverbandes Dresden und in neuseeländischen Honigen. Im Vergleich zu den Milchprodukten wurden deutlich höhere Gesamtgehalte an 1,2-Dicarbonylverbindungen (124 bis 1550 mg/ kg) bestimmt. Für 3-Desoxyglucosulose wurden 119 bis 1451 mg/ kg, für Glyoxal 0,2 bis 4,6 mg/ kg und für Methylglyoxal 0,5 bis 743 mg/ kg ermittelt. Ein Zusammenhang zwischen hohen Gehalten an 1,2-Dicarbonylverbindungen und der antibakteriellen Aktivität der Honige wurde untersucht. Hier stellten die neuseeländischen Manuka-Honige (Manuka: Leptospermum scoparium, Teebaum) den Schwerpunkt der Untersuchung dar. Für die untersuchten Manuka-Honige konnten ungewöhnlich hohe Gehalte an Methylglyoxal bestimmt werden (von 347 bis 743 mg/ kg). Von 12 verschiedenen Honigen deutscher und neuseeländischer Herkunft konnten nur Manuka-Honige als antibakteriell wirksam eingestuft werden. Bezogen auf den Gehalt an Methylglyoxal liegen die MIC-Werte für Staphylococcus aureus bei 1,5 mmol/ l für Manuka-Honig (35 % v/v), 1,4 mmol/ l für Manuka-Honig "active" (30 % v/v), 1,1 mmol/ l für Manuka-Honig UMF 10+ (25 % v/v) bzw. 1,8 mmol/ l für Manuka-Honig UMF 20+ (20 % v/v). Es zeigte sich, dass die antibakterielle Aktivität des Honigs unmittelbar auf den Methylglyoxal-Gehalt zurückführbar war.

Reaktion von Arginin mit Abbauprodukten 1,4-verknüpfter Disaccharide Im Verlauf der Reaktion von Arginin mit Abbauprodukten 1,4-glycosidisch verknüpfter Disaccharide entsteht ein Hauptderivatisierungsprodukt des Arginins, welches aus Inkubationsansätzen von Lactose mit N-(tert-Butoxycarbonyl)-L-arginin (Boc-Arg) bzw. N-a-Hippuryl-L-arginin (Hip-Arg) isoliert und als N-d-[5-(3-Hydroxypropyl)-4-oxo-imidazolon-2-yl]-L-ornithin (PIO) identifiziert werden konnte. PIO stellt ein spezifisches Reaktionsprodukt von Arginin mit Abbauprodukten 1,4-glycosidisch verknüpfter Disaccharide dar. Zum Nachweis des Precursors von PIO wurden die Bildung und der Abbau von 1,2-Dicarbonylverbindungen in Inkubationsansätzen von Lactose mit und ohne Hip-Arg nach der Hitzebehandlung mit o-Phenylendiamin untersucht. Es zeigte sich, dass ein als 1,2-Dicarbonylverbindung identifiziertes Abbauprodukt von Lactose nur in Abwesenheit von der Aminokomponente (Hip-Arg) als Hauptabbauprodukt bestimmbar war. Nach Isolierung dieser 1,2-Dicarbonylverbindung in Form ihres stabilen Chinoxalin-Derivates und der Strukturaufklärung ist es gelungen, dieses Hauptabbauprodukt der Lactose als (3'-Hydroxypropyl)-chinoxalin also das Chinoxalin der 3,4-Didesoxypentosulose (3,4-DDPs) zu identifizieren. Bestimmung von 1,2-Dicarbonylverbindungen in Lebensmitteln Glyoxal (GO), Methylglyoxal (MGO), 3-Desoxyglucosulose (3-DG) und 3-Desoxypentosulose (3-DPs) konnten nach Umsetzung mit o-Phenylendiamin erstmals in Milch- und Milchprodukten quantifiziert werden. Für Glyoxal wurden Gehalte von 0,06 bis 3,5 mg/ l und für Methylglyoxal von 0,2 bis 4,7 mg/ l bestimmt. 3-Desoxyglucosulose wurde mit Gehalten von 0,7 bis 3,5 mg/ l und 3-Desoxypentosulose von 0,1 bis 4,7 mg/ l bestimmt. Des Weiteren erfolgte die Bestimmung von Glyoxal, Methylglyoxal und 3-Desoxyglucosulose in käuflich erworbenen deutschen Honigen, in Honigen des Imkerverbandes Dresden und in neuseeländischen Honigen. Im Vergleich zu den Milchprodukten wurden deutlich höhere Gesamtgehalte an 1,2-Dicarbonylverbindungen (124 bis 1550 mg/ kg) bestimmt. Für 3-Desoxyglucosulose wurden 119 bis 1451 mg/ kg, für Glyoxal 0,2 bis 4,6 mg/ kg und für Methylglyoxal 0,5 bis 743 mg/ kg ermittelt. Ein Zusammenhang zwischen hohen Gehalten an 1,2-Dicarbonylverbindungen und der antibakteriellen Aktivität der Honige wurde untersucht. Hier stellten die neuseeländischen Manuka-Honige (Manuka: Leptospermum scoparium, Teebaum) den Schwerpunkt der Untersuchung dar. Für die untersuchten Manuka-Honige konnten ungewöhnlich hohe Gehalte an Methylglyoxal bestimmt werden (von 347 bis 743 mg/ kg). Von 12 verschiedenen Honigen deutscher und neuseeländischer Herkunft konnten nur Manuka-Honige als antibakteriell wirksam eingestuft werden. Bezogen auf den Gehalt an Methylglyoxal liegen die MIC-Werte für Staphylococcus aureus bei 1,5 mmol/ l für Manuka-Honig (35 % v/v), 1,4 mmol/ l für Manuka-Honig "active" (30 % v/v), 1,1 mmol/ l für Manuka-Honig UMF 10+ (25 % v/v) bzw. 1,8 mmol/ l für Manuka-Honig UMF 20+ (20 % v/v). Es zeigte sich, dass die antibakterielle Aktivität des Honigs unmittelbar auf den Methylglyoxal-Gehalt zurückführbar war.

In the past 15 years, many efforts were made to create functionalized artificial surfaces showing special anti-bacterial and anti-biofouling properties. Thereby, the topography of medical relevant materials plays an important role. However, the targeted fabrication of promising surface structures like hole-, lamella- and pyramid-like patterns with feature sizes in the sub-micrometer range in a one-step process is still a challenge. Optical and e-beam lithography, molding and selfassembly layers show a great potential to design topographies for this purpose. At the same time, most of these techniques are based on sequential processes, require masks or molds and thus are very device relevant and time consuming. In this work, we present the Direct Laser Interference Patterning (DLIP) technology as a capable method for the fast, flexible and direct fabrication of periodic micrometer- and submicrometer structures. This method offers the possibility to equip large plain areas and curved devices with 1D, 2D and 3D patterns. Simple 1D (e.g. lines) and complex 3D (e.g. lamella, pillars) patterns with periodic distances from 0.5 μm to 5 μm were fabricated on polymeric materials (polyimide, polystyrene). Subsequently, we characterized the adhesion behavior of Staphylococcus epidermidis and S. aureus bacteria under in vitro and in vivo conditions. The results revealed that the topographies have a significant impact on bacteria adhesion. On the one side, one-dimensional line-like structures especially with dimensions of the bacteria enhanced microbe attachment. While on the other hand, complex three-dimensional patterns prevented biofilm formation even after implantation and contamination in living organisms.

Reaction of BiPh3 or Bi(OtBu)3 with benzohydroxamic acid (H2-BHA) results in formation of novel mono- and di-anionic hydroxamato complexes; [Bi2(BHA)3]∞1, [Bi(H-BHA)3] 2, [Bi(BHA)(H-BHA)] 3, all of which display nM activity against Helicobacter pylori. Subsequent dissolution of [Bi2(BHA)3]∞ in DMSO/toluene results in hydrolysis to the first structurally authenticated {Bi34} oxido-cluster [Bi34O22(BHA)22(H-BHA)14(DMSO)6] 4. / Dieser Beitrag ist aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.

Lactic acid bacteria were isolated from 10 samples of the traditionally fermented foods (5 samples of Vietnamese fermented pork roll and 5 samples of the salted field cabbage) and 5 samples of fresh cow milks collected from households in Vietnam. 22 strains of lactic acid bacteria were isolated for inhibition to Lactobacillus plantarum JCM 1149. Of these, only 2 strains including DC1.8 and NC1.2 have rod shape, the others have coccus shape. 7 strains showing higher antibacterial activity were selected for checking spectrum of antibacteria with indicator bacteria consistting of Bacillus subtilis ATCC 6633, Enterococcus faecium JCM 5804 and Staphylococcus aureus TLU. By which, 3 strains including NC3.5 (from Vietnamese fermented pork roll), DC1.8 (from salted field cabbage) and MC3.19 (from fresh cow milk) were selected because of their higher antibacterial ability. However, the antibacterial activity of the lactic acid bacteria can be based on their disposable compounds and some other antibacterial compounds produced during their growth (such as lactic acid, H2O2, bacteriocins, etc.). For seeking lactic acid bacteria with capability of producing bacteriocins, antibacterial compounds with protein nature, 3 above strains were checked sensitiveness to proteases (including protease K, papain, α – chymotrypsin and trypsin). Because bacteriocins are proteinaceous antibacterial compounds, so their antibacterial activity will be reduced if proteases are added. The result showed DC1.8 and MC3.19 were capable of producing bacteriocin during culture process. They were identified as Lactobacillus acidophilus and Lactococcus lactis and classified, respectively, based on analysis chemical characterisitcs by standard API 50 CHL kit and phylogeny relationship by 16s rRNA sequences. / Các chủng vi khuẩn lactic được phân lập từ 10 mẫu thực phẩm lên men truyền thống (5 mẫu nem chua, 5 mẫu dưa cải bẹ muối) và 5 mẫu sữa bò tươi được thu thập từ các hộ gia đình ở Việt Nam. 22 chủng vi khuẩn lactic đã được phân lập với tiêu chí có khả năng kháng lại vi khuẩn kiểm định Lactobacillus plantarum JCM 1149. Trong số đó, 2 chủng DC1.8 và NC1.2 có tế bào hình que, các chủng còn lại có tế bào hình cầu. 7 chủng thể hiện hoạt tính kháng khuẩn cao được lựa chọn để xác định phổ kháng khuẩn rộng hơn với ba loài vi khuẩn kiểm định Bacillus subtilis ATCC 6633, Enterococcus faecium JCM 5804 và Staphylococcus aureus TLU. Từ đó lựa chọn được 3 chủng có hoạt tính kháng khuẩn cao hơn hẳn. Các chủng này gồm NC3.5 phân lập từ nem chua, DC1.8 phân lập từ dưa cải bẹ muối và MC3.19 phân lập từ sữa bò tươi. Tuy nhiên, hoạt tính kháng khuẩn của vi khuẩn lactic bao gồm những hợp chất nội tại có trong nó và cả những hợp chất được sinh ra trong quá trình phát triển của nó (như axit lactic, H2O2, bacteriocin, …). Với định hướng tìm chủng vi khuẩn lactic có khả năng sinh bacteriocin, chất kháng khuẩn có bản chất protein, 3 chủng trên được kiểm tra độ nhạy cảm với các protease (gồm protease K, papain, α – chymotrypsin và trypsin). Do bacteriocin là chất kháng khuẩn có bản chất protein nên hoạt tính kháng khuẩn của chúng sẽ bị giảm nếu protease được bổ xung vào. Kết quả lựa chọn được chủng DC1.8 và MC3.19 có khả năng sinh bacteriocin. Hai chủng này được phân loại đến loài nhờ vào phân tích đặc điểm sinh hóa bằng kit API 50 CHL và mối quan hệ di truyền thông qua trình tự gen 16s rRNA. Kết quả phân loại đã xác định chủng DC1.8 thuộc loài Lactobacillus acidophilus và chủng MC3.19 thuộc loài Lactococcus lactis.